Momentum Continuation · 2026-06-19 · Pharmaceuticals & Drugs
ORCHPHARMA
Orchid Pharma Ltd.
Watchlist-worthy setup
Setup readiness
Early Trend
- Entry Zone
- ₹1088.5-1099.5
- Support Level
- ₹984.6
- Resistance
- ₹1312.8
- Risk / Reward
- 1.9 : 1
- Risk Distance
- 10.4% to stop
Reference levels for educational study only. Not a recommendation to buy or sell.
Swing Edge Intelligence
Structured setup analysis · research only
Setup status · Constructive setup
Structure shows workable momentum characteristics with selective risks to monitor.
Bullish factors
- Failure flags: Overextended.
- Gain 10d: 16.0% / 20d: 38.4%.
- Overextended 36% above MA50 (chase risk, score −2).
- RSI 72 (89th pct 1y, ATR vol 99th pct).
- Stage2: 7/8.
- Vol: 6.5x 50d avg [spike ✓].
Risk factors
- Stop is 10% away — too wide to size well for a swing
- 3 distribution days recently — institutional selling
Why not 100?
- Volume quality is not in top confirmation range yet
Overall view
Constructive setup — key momentum and institutional cues are broadly aligned for continued research.
Trade management framework
Research framework only. Use your own risk controls.
- If price moves +1R, consider reducing downside by moving stop closer to entry.
- If price reaches around +1.5R to +2R, consider partial profit booking (for example 20-30%).
- If trend extends beyond +2R, consider trailing below a fast trend reference (for example 21 EMA).
Setup research
ORCHPHARMA — trend, RS & risk snapshot (not a trade recommendation)
Signal · context · invalidation · risk · skip reasons — research only
Why now
Breaking out — price is clearing the pivot now
- Confirmed Stage 2 uptrend
Context & regime
- Market regime Mixed / range-bound
- Trend stage Stage 2 — tradable
- Sector Lagging (#20/30) — headwind
- Relative strength Leader (RS 100)
- Trend strength Strong (ADX 67)
What invalidates it
This idea is wrong below ₹984.6 (-0.6% away)
Base / stop support breaks — the swing thesis is wrong below here
- Stop / base low₹984.6
- Pivot — failure re-entry below₹1094.0
Risk distance
Risk ≈ ₹114.89/share from entry ₹1099.5.
Stop is wide (10%) for a swing — sizing will be small
Reasons to skip 2
Disqualifiers that apply even if the score looks good.
- Stop is 10% away — too wide to size well for a swing
- 3 distribution days recently — institutional selling
ORCHPHARMA Support & Resistance Levels
Research chart
Daily price action with entry, stop, and target levels from our latest scan, plus relative strength vs Nifty.
Entry zone, stop and targets are drawn on the price chart. · Research only.
Sector RS rank · latest scan
Loading peer comparison…
Trader brief
What to understand
ORCHPHARMA Entry, Stop-Loss & Targets
Research heuristic · not a buy/sell call
Mixed structure — some positives, but not a clean A+ setup yet. Watch for stronger RS and clearer volatility contraction before treating this as actionable.
AI insights
AI Insights
Generated with AIThese insights are AI-generated to support your research process and should not be treated as investment advice or a recommendation to buy or sell securities.
Sign in to unlock AI Insights
Personalised swing trade analysis powered by Gemini AI
Pattern context 52w · setup · flow
52-week range
—Stage-2 ideal band · Early recovery
Setup highlights
Pattern signals from the latest scan
Smart money flow
Last 60 sessions · accumulation vs distribution
Setup intelligence Overhead · VCP · radar · risk
Overhead supply
Resistance ceiling above current price
Chase / failure risk
Honest read on exhaustion & extended moves
Base / VCP coil
Depth, contractions & pivot distance
Setup quality radar
Shape of the setup in one view
Scanner journey Proof board · first flag to now
Scanner journey
Setup metrics Moderate · 74.0
ORCHPHARMA Technical Analysis & Swing Setup
Grouped structure, momentum and risk from the latest momentum continuation scan.
Structure
Momentum
Risk
More scanner fields
Peer comparison Sector peers
Sector Peer Comparison
Loading sector peers…
ORCHPHARMA FAQ Common swing-trading questions
Frequently asked questions about ORCHPHARMA
Is ORCHPHARMA a good swing trade right now?
On Swing Edge's swing-setup framework, Orchid Pharma Ltd. (ORCHPHARMA) currently grades B — workable setup. Breaking out — price is clearing the pivot now. Flagged today. This is educational research, not investment advice.
What are ORCHPHARMA's support and resistance levels?
For ORCHPHARMA, near-term support sits around ₹984.6 (the base/stop zone); overhead resistance is around ₹1,094.0 (the breakout pivot); the next resistance above is ₹1,312.8. This is educational research, not investment advice.
What is the breakout / pivot level for ORCHPHARMA?
The breakout pivot for ORCHPHARMA is around ₹1,094.0. Price is about 10.5% below the pivot and still building toward it. A breakout is typically confirmed on a close above the pivot with above-average volume. This is educational research, not investment advice.
Is ORCHPHARMA above its 50-day and 200-day moving averages?
Yes — ORCHPHARMA is in a confirmed Stage 2 uptrend, trading above its rising 50- and 200-day moving averages, the zone where swing setups tend to work best. This is educational research, not investment advice.
How strong is ORCHPHARMA versus the market (RS rank)?
ORCHPHARMA has a relative strength (RS) rank of 100 out of 100 versus the NSE universe, making it a market leader — stronger than most NSE stocks. Trend strength (ADX) reads 67, indicating a strong trend. This is educational research, not investment advice.
What are the entry, stop-loss and target levels for ORCHPHARMA?
Reference swing levels for ORCHPHARMA: entry around ₹1,099.5, stop-loss around ₹984.6, targets at ₹1,312.8 and ₹1,758.4. That works out to roughly a 1.9:1 reward-to-risk on the first target. These are reference levels for study only — this is educational research, not investment advice.
Answers are generated from Swing Edge's latest scan data and are for research only — not investment advice.
Prices and day-change figures use the last daily close from scan data dated 2026-06-19 — not live intraday NSE quotes.